China Resources Pharmaceutical Group Limited (3320.HK)
HKD 4.97
(-0.4%)
HKD 4.97
(-0.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 50.97 Billion HKD | 18.89% |
| 2022 | 42.87 Billion HKD | -25.11% |
| 2021 | 57.25 Billion HKD | 39.97% |
| 2020 | 40.9 Billion HKD | 9.43% |
| 2019 | 37.38 Billion HKD | -19.75% |
| 2018 | 46.58 Billion HKD | 34.66% |
| 2017 | 34.59 Billion HKD | 33.73% |
| 2016 | 25.86 Billion HKD | -26.64% |
| 2015 | 35.26 Billion HKD | 47.88% |
| 2014 | 23.84 Billion HKD | 48.66% |
| 2013 | 16.04 Billion HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 67.22 Billion HKD | 0.0% |
| 2023 FY | 50.97 Billion HKD | 18.89% |
| 2023 Q4 | 37.51 Billion HKD | 0.0% |
| 2023 Q2 | 58.32 Billion HKD | 0.0% |
| 2022 FY | 42.87 Billion HKD | -25.11% |
| 2022 Q2 | 63.6 Billion HKD | 0.0% |
| 2022 Q4 | 42.87 Billion HKD | 0.0% |
| 2021 Q4 | 57.25 Billion HKD | 0.0% |
| 2021 Q2 | 57.39 Billion HKD | 0.0% |
| 2021 FY | 57.25 Billion HKD | 39.97% |
| 2020 Q4 | 40.9 Billion HKD | 0.0% |
| 2020 Q2 | 53.98 Billion HKD | 0.0% |
| 2020 FY | 40.9 Billion HKD | 9.43% |
| 2019 Q4 | 37.38 Billion HKD | 0.0% |
| 2019 FY | 37.38 Billion HKD | -19.75% |
| 2019 Q2 | 56.3 Billion HKD | 0.0% |
| 2018 FY | 46.58 Billion HKD | 34.66% |
| 2018 Q4 | 34.3 Billion HKD | 0.0% |
| 2018 Q2 | 34.06 Billion HKD | 0.0% |
| 2017 Q4 | 22.71 Billion HKD | 0.0% |
| 2017 FY | 34.59 Billion HKD | 33.73% |
| 2017 Q2 | 19.64 Billion HKD | 0.0% |
| 2016 Q2 | 27.25 Billion HKD | 0.0% |
| 2016 Q4 | 11.75 Billion HKD | 0.0% |
| 2016 FY | 25.86 Billion HKD | -26.64% |
| 2015 FY | 35.26 Billion HKD | 47.88% |
| 2015 Q4 | 24.83 Billion HKD | 0.0% |
| 2014 FY | 23.84 Billion HKD | 48.66% |
| 2013 FY | 16.04 Billion HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 19805.801% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | -2409.008% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -857563.166% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -16806.604% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | 267877.595% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -164626.31% |
| Essex Bio-Technology Limited | -219.22 Million HKD | 23353.991% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -19801.117% |
| PuraPharm Corporation Limited | 377.54 Million HKD | -13402.75% |
| SSY Group Limited | 1.71 Billion HKD | -2875.128% |
| JBM (Healthcare) Limited | -7.39 Million HKD | 689105.252% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | -15007.633% |